Viewpoint: How Boston’s life sciences industry can lead and improve public health


Boston is home to the nation’s largest biopharma cluster. As the Business Journal has reported, Massachusetts-based life sciences companies are pulling in record breaking investments. But just as the sector is growing, so is competition.

To maintain dominance in the future, these pharma companies will need to exhibit a new kind of leadership — one that speaks to the new role of the pharmaceutical industry in American life. In our new study, M Booth Health found that consumers have developed…

Previous Almost 40% of Atlantans work from home. That's affecting how apartments are designed.
Next How employers can improve uptake of recommended cancer screenings